Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
bone marrow disorder
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Amgen
AstraZeneca
bone marrow disorder
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
Pluristem
F.D.A. Approves Drug for Bone Marrow Disease
F.D.A. Approves Drug for Bone Marrow Disease
NY Times, NY
bone marrow disorder
FDA
Incyte
JAK inhibitors
Jakafi
myelofibrosis
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT